Resistance to PI3κδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis See

State of art of dose individualization to support tacrolimus drug monitoring: What’s next? See

Editorial: Mitochondrial proteomics: Understanding mitochondria function and dysfunction through the characterization of their proteome See

Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown See